Postoperative Nausea and Vomiting - Risk Score and Multimodal Prophylaxis

Key Points

• Risk-stratify PONV before anesthesia rather than treating everyone identically.
• The simplified Apfel score uses female sex, nonsmoking, prior PONV or motion sickness, and expected postoperative opioids.
• Reduce baseline risk with opioid-sparing analgesia, regional techniques, adequate hydration, and propofol-based anesthesia when appropriate.
• Use multiple prophylactic interventions from different classes for patients at increased risk.
• Dexamethasone and 5-HT3 antagonists are common components of multimodal prophylaxis.
• Breakthrough PONV should generally be treated with a different drug class from the prophylactic regimen.
• Persistent vomiting should trigger assessment for hypotension, pain, ileus, swallowed blood, or a surgical complication.
• Plan for postdischarge nausea in high-risk ambulatory patients.

Algorithm

1. Assess adult PONV risk factors and procedure-related risks during preoperative planning.
2. Reduce modifiable baseline risk with opioid-sparing analgesia and anesthetic choices when feasible.
3. Select multimodal prophylaxis proportional to risk using different antiemetic classes.
4. Administer agents at timing appropriate to their pharmacology.
5. In PACU, treat nausea or vomiting early and correct hypotension, hypovolemia, pain, or other contributors.
6. If prophylaxis fails, choose a rescue medication from a different pharmacologic class when possible.
7. For persistent or atypical symptoms, evaluate for medical or surgical complications.
8. Before discharge, ensure symptoms are controlled and provide postdischarge instructions for high-risk patients.

Clinical Synopsis & Reasoning

PONV includes nausea, retching, or vomiting after anesthesia and can delay oral intake, mobilization, medication administration, and discharge. Severe vomiting can contribute to dehydration, electrolyte disturbance, wound stress, aspiration, hematoma after selected operations, or unexpected admission. Risk assessment allows prophylaxis to be matched to the patient rather than waiting for symptoms.

The simplified Apfel score for adults uses four major predictors: female sex, nonsmoking status, a history of PONV or motion sickness, and expected postoperative opioid use. Risk increases as factors accumulate. Procedure type, volatile anesthetic exposure, nitrous oxide, duration of anesthesia, and opioid dose can further influence risk. In children, different risk factors and scoring systems apply, including age, duration, strabismus or selected surgery types, and personal or family history.

Baseline-risk reduction is part of prevention. Use opioid-sparing analgesia, adequate hydration, and regional or local techniques when appropriate. Propofol-based total intravenous anesthesia reduces PONV compared with volatile maintenance in susceptible patients. Avoiding or minimizing volatile anesthetics, nitrous oxide, and unnecessary opioids can reduce risk when clinically feasible. These measures complement rather than replace antiemetic prophylaxis.

Current consensus guidance favors multimodal prophylaxis, using drugs from different mechanistic classes, for patients with meaningful risk. Common choices include dexamethasone near induction, a 5-HT3 antagonist near the end of surgery, droperidol or haloperidol in selected patients, an NK1 antagonist for very high-risk situations, transdermal scopolamine when appropriate, and other institution-approved options. Choice should consider QT interval, sedation risk, glaucoma, anticholinergic burden, pregnancy, drug interactions, and procedure-specific concerns.

Treatment Strategy & Disposition

Provide prophylaxis before symptoms emerge based on risk. A patient with multiple Apfel factors should generally receive more than one preventive intervention using different mechanisms. Dexamethasone is commonly administered after induction; ondansetron or another 5-HT3 antagonist is commonly given toward the end of anesthesia. Additional classes can be layered for higher-risk patients. The exact regimen should follow institutional formulary and current consensus guidance.

When PONV occurs despite prophylaxis, treat promptly. Whenever possible, choose a rescue antiemetic from a pharmacologic class not already administered. Simply repeating the same short-acting agent within its active window is less likely to help. Assess for reversible contributors such as hypotension, hypovolemia, severe pain, excessive opioid dosing, swallowed blood, gastric distention, ileus, or motion during transport. Persistent vomiting after an initially routine recovery should also prompt consideration of a surgical or medical complication.

Use IV fluids when volume depletion contributes. Optimize analgesia with opioid-sparing measures. If the patient has not received prophylaxis, a 5-HT3 antagonist is a common first rescue choice. Droperidol, haloperidol, amisulpride, promethazine, metoclopramide, NK1 antagonists, or other options may be appropriate depending on previous drugs, contraindications, and local practice. Monitor QT-prolonging combinations and sedation.

For ambulatory surgery, consider postdischarge nausea and vomiting when selecting longer-acting prophylaxis. Patients with repeated prior severe PONV benefit from documenting the successful anesthetic and prophylactic combination for future procedures. Unexpectedly severe or prolonged symptoms warrant reassessment rather than serial antiemetic dosing alone.

Epidemiology / Risk Factors

• PONV is among the most common patient-reported adverse effects after anesthesia.
• Risk varies widely, from low in patients with few risk factors to very high in patients with several predictors.
• Use of multimodal prophylaxis has expanded because single-agent prevention is often inadequate in high-risk patients.
• Postdischarge nausea and vomiting remains important after ambulatory surgery even when PACU symptoms are controlled.

Investigations

Common Antiemetic Classes

Pharmacology

Prognosis / Complications

• Most PONV resolves with prophylaxis, rescue treatment, hydration, and time.
• Refractory symptoms can prolong recovery and cause unplanned admission.
• Patients with a strong personal history frequently recur unless a preventive strategy is used.
• Documenting successful multimodal regimens improves future planning.

Patient Education / Counseling

• Ask patients about prior nausea after anesthesia and motion sickness because both alter prophylaxis.
• Explain that several medications may be used preventively because they work through different pathways.
• Advise ambulatory patients what to do if nausea or vomiting occurs after discharge.
• Give return precautions for persistent inability to hydrate, severe abdominal pain, hematemesis, dyspnea, or other concerning symptoms.
• Patients with prior severe PONV should tell future anesthesia teams which regimen was successful.

Notes

PONV prevention is best viewed as a bundle: identify risk, reduce emetogenic anesthetic exposures when practical, provide multimodal prophylaxis, and use mechanistically different rescue treatment. Increasing the number of medications without considering class duplication or adverse effects is not the same as rational multimodal care.

Patients often remember severe postoperative nausea long after they forget other details of an anesthetic. Treating prevention as a quality-of-recovery outcome can meaningfully improve the perioperative experience.

References

1. Fifth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting, Executive Summary — Link
2. Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting — Link